Plasma metabolomic profile varies with glucocorticoid dose in patients with congenital adrenal hyperplasia
Sign Up to like & getrecommendations! Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-17220-5
Abstract: Glucocorticoid replacement therapy is the mainstay of treatment for congenital adrenal hyperplasia (CAH) but has a narrow therapeutic index and dose optimisation is challenging. Metabolomic profiling was carried out on plasma samples from 117 adults… read more here.
Keywords: glucocorticoid dose; adrenal hyperplasia; plasma metabolomic; congenital adrenal ... See more keywords
No need of glucocorticoid dose adjustment in patients with adrenal insufficiency before COVID-19 vaccine.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of endocrinology"
DOI: 10.1530/eje-21-1236
Abstract: Objective Coronavirus disease-2019 (COVID-19) causes acute respiratory distress syndrome. Patients with adrenal insufficiency (AI) may develop severe complications due to this infection and should undergo COVID-19 vaccination; however, there is no consensus about the management… read more here.
Keywords: need glucocorticoid; patients adrenal; covid; vaccine ... See more keywords